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I. RESUM 
Aquest Treball Fi de Grau es basa en la recerca bibliogràfica i la integració d’articles 
científics recents, que contenen informació relacionada amb la llum i els seus efectes 
en l’organisme; i pretén donar a conèixer que els humans necessitem la llum, no 
només per la visió o funcions conegudes, com la síntesi de Vitamina D, sinó també pels 
seus efectes no visuals. 
La llum és captada i transformada en informació que va directa al cervell per una petita 
població de cèl·lules ganglionars de la retina que són intrínsecament fotosensibles. 
Aquesta informació extreta de l’ambient permet a l’organisme regular diverses 
funcions fisiològiques i de comportament que són essencials per una bona salut i 
qualitat de vida.  
Aquest conjunt de funcions no visuals inclouen la sincronització dels ritmes circadiaris i 
estacionals, i la regulació del son, l'estat d'alerta, l’humor i el rendiment cognitiu, que 
estan interconnectades entre elles, i amb altres processos fisiològics i fisiopatològics 
com l’envelliment, processos metabòlics, desenvolupament de càncer i conseqüències 
cardiovasculars, per tant, l’alteració d’alguna d’aquestes funcions pot provocar danys 
en altres sistemes i acabar afectant tot l’organisme. 
És molt important per això, controlar l’exposició a la llum en certs moments del dia, ja 
que no afecta de la mateixa manera la llum al matí que a la nit. Aquesta propietat però 
permet el seu ús per tractar aquests trastorns, per tant, l'educació en l’estil de vida del 
pacient i la realització de dissenys arquitectònics més eficaços per entorns 
d'il·luminació com escoles i treballs són potencialment beneficiosos. 
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II. ABSTRACT 
This Final Project is based on bibliographic research and integration of recent scientific 
articles that contain information related to light and its effects on the body; and aims 
to raise awareness that humans need light, not only for vision or known functions such 
as the synthesis of vitamin D, but also for non-visual effects. 
Light is detected and transformed into information that goes direct to the brain 
through a small population of intrinsically photosensitive retinal ganglion cells. This 
information obtained from the environment allows the body to regulate several 
physiological and behavioural functions that are essential for a good health and quality 
of life. 
This set of non-visual functions include the synchronization of circadian and seasonal 
rhythms and the regulation of sleep, alertness, mood and cognitive performance, 
which are interconnected with each other and with other physiological and 
pathophysiological processes such as aging, metabolic processes, development of 
cancer and cardiovascular consequences, so the alteration of any of these functions 
can cause damage to other systems and ultimately affect the entire body. 
It is important therefore to control light exposure at certain times of day, because light 
in the morning does not affect the same way than light at night. This property allows 
its use for treating these disorders; therefore, patient lifestyle education and more 
effective architectural designs for lighting environments like schools and work are 
potentially beneficial. 
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III. BRIEF DISCUSSION OF THE EDUCATIONAL SCOPES’ INTEGRATION 
This review about light as a medicine encompasses three different educational scopes 
that are connected at concept level. The core of the work lies in the main scope of 
Physiology and Pathophysiology, but also includes other educational scopes such as 
Biochemistry and Molecular Biology, and Nutrition and Food Science. 
Regarding the main scope, firstly, there is a brief anatomical and physiological 
description of the retina, the part of the body responsible for light detection and 
information transmission to the brain. Then, there is a more detailed description of the 
parts of the brain that integrate this information for continuously regulating biological 
rhythms, depending on the presence or absence of light during the day. In addition to 
the circadian photoentrainment, light also affects sleep, alertness, mood and cognitive 
performance, therefore, physiology and pathophysiology of these processes, due to 
changes in light detection and/or transmission, is also explained. 
This section of circadian regulation also includes concepts of Biochemistry and 
Molecular Biology, as it explains the molecular machinery responsible for the 
synchronization of internal rhythms with day-night cycles, and its operation at gene 
transcription and protein synthesis levels. 
Finally, in the pathophysiological part of the review, which includes issues related to 
aging, cancer and cardiovascular consequences, there is a point of metabolic disorders 
related to circadian disruption, such as diabetes and obesity. This point explains that 
changes in light-dark cycles, like those produced by schedule changes in shift workers, 
are related to excessive food intake and trend poor nutrition, based in a diet rich in fat 
and carbohydrates, including thereby concepts of Nutrition and Food Science. 
These three scopes are part of a set of scopes that integrate the Bachelor of Pharmacy, 
and pharmacists have an important role in giving health advices to patients, therefore, 
we have to be able to raise awareness of the importance of light exposure at certain 
day times and the need of darkness in others to get a good health and quality of life. 
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IV. OBJECTIVES 
• To analyze the different functions of light on the body, focusing on the non-visual 
effects triggered by the intrinsically photosensitive retinal ganglion cells (ipRGCs). 
• To study the neural pathways of these non-visual effects of light, from the day-night 
cycle synchronization, or circadian photoentrainment, to the regulation of sleep, 
alertness, mood and cognitive performance. 
• To understand the relationship between the non-visual effects of light and its 
chronodisruption, and the physiological and pathophysiological processes in the 
body, such as aging, metabolic processes, cancer and cardiovascular consequences. 
• To raise awareness of the importance of exposure to light at certain times of day, 
and the consequences of alterations in light-dark cycles due to seasonal changes in 
day length and schedule changes. 
 
V. MATERIALS AND METHODS 
The methodology used for conducting this review was based on a bibliographic 
research of information related to the proposed topic: “Blue light as a drug?” 
Firstly, basic general information of the topic was drawn from the book (1) Cambras 
Riu T, Díez Noguera A. “Els Ritmes de la vida : Com la cronobiologia ens ajuda a viure 
millor”, cited in the bibliography. 
Then, more specific information was mainly extracted from scientific articles, obtained 
from searching in the database PUBMED (http://www.ncbi.nlm.nih.gov/pubmed), a 
platform developed by the National Centre for Biotechnology Information (NCBI) that 
allows access to most full-text journals. 
The other scientific papers were obtained through access provided by the “Centre de 
Recursos per a l'Aprenentatge i la Investigació de la Universitat de Barcelona” (CRAI 
UB) to several scientific journals.  
Many articles related to the topic were found, but only those published from 2008 
until now were used to perform this work, despite that some of them are reviews, 
which include publications of previous years. 
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VI. INTRODUCTION 
The earth rotation on its axis results in periodic changes in the light-dark environment. 
These predictable changes exert great influence on plants, animals and humans, and 
allow these organisms to confine their behaviour and physiology to specific times of 
the day-night cycle. This means that the solar day limits their activities to the correct 
temporal niche. 
To anticipate these light-dark changes, organisms have evolved an internal biological 
pacemaker, a circadian timing system which acts as an endogenous representation of 
the external 24h clock. Despite this, the intrinsic oscillation period of this pacemaker is 
not exactly 24h, in humans it is 24,2h in absence of environmental influences; 
therefore, this circadian timing system requires daily resynchronization through 
external time cues, called zeitgebers. The major zeitgeber is daily retinal illumination 
through exposure to environmental light, which represents the primary indicator of 
the time of day (2–5). 
Under normal conditions, organisms experience a 24 hour pattern of light-dark (LD), 
and the circadian system of most of them uses the twilight transitions to align to 
external time; but also other environmental factors such as temperature, meals, 
exercise and social cues, including employment, families and alarm clocks, may 
influence the circadian rhythms. Hence, they can also affect the circadian clock 
outputs, which include sleep/wake and metabolic cycles as well as hormonal changes. 
Indeed, circadian rhythm disturbances encompass a number of disorders which can 
result from either exogenous or endogenous disturbances, or a combination of both 
(4). So, proper alignment between light, the circadian pacemaker, and output 
behaviours produces a temporal order in organisms that is essential for survival. 
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1. Light influences on health  
Light has strongly influenced the evolution of life on earth. As widely appreciated, light 
allows us to generate images of our environment; however, it also lets us the 
regulation of several behavioural and physiological functions that are essential for our 
health and quality of life.  
For instance, environmental light is the major responsible for vitamin D production, 
which is very important for calcium homeostasis, indeed, a deficit of vitamin D 
increases the risk of suffering rickets in children and osteoporosis in adults. Moreover, 
UV light is really useful for removing the bilirubin excess from skin and mucous of 
newborns with fetal erythroblastosis, which could cause jaundice or even irreversible 
damage to the CNS (kernicterus). Furthermore, UV light is also used for other skin 
treatments in adults such as psoriasis, vitiligo, cutaneous T-cell lymphoma and atopic 
dermatitis. 
Regardless all the possible effects of light on humans' behaviours and health, this 
project will be focused on light detection through the retina and its most innovative 
aspects. 
 
2. Light detection  
Light detection through the retina not only supports pattern vision, but also has 
profound effects on many aspects of human physiology and behaviour that are 
independent of image formation, such as synchronizing and resetting of properties of 
the endogenous circadian pacemaker, pupillary constriction, heart rate, sleep 
regulation and alertness, body temperature, brain activity and cognition, hormonal 
secretion (melatonin) and clock gene expression (2,6–8). 
Light exposure at different times of the day can alter circadian rhythms, that is, 
changes in the timing of the LD cycle (e.g. a nocturnal light exposure) result in shifts in 
the phase of circadian rhythms; for instance, suprathreshold early morning light 
advances, while evening light delays rhythms (5,8). So, an adequate light exposure in 
the correct time is important for the proper maintenance of physiological processes. 
The phase-shifting effect of light can only be detected in the longer term (i.e. in the 
next circadian cycle), but the effects of light are not limited to these long-term effects; 
the effects of light on circadian physiology can be observed during or immediately 
after the light exposure. Thus, these effects can be acute (seconds for brain responses) 
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or extend beyond the light exposure (hours for hormone secretion). Although the 
acute effects of light were first studied using bright light, it has emerged that they can 
also be elicited by ordinary room light or even dimmer light (6,8). 
The long term and acute effects of light on circadian physiology are referred to as non-
visual or non-image forming (NIF) effects of light because they are not directly related 
to vision and because they present several features that distinguish them from the 
visual system (8). These NIF effects will be explained later in more detail, but first, it is 
necessary to introduce the structure and functions of the light detection system in 
humans.  
2.1.  The retina  
The human retina, located in the back of the eye, is a complex transparent tissue 
consisting of several layers, only one of which contains light-sensitive photoreceptor 
cells. So, light must pass through the overlying layers to reach these cells (9). 
2.1.1.  Photoreceptor cells 
A photoreceptor cell is a specialized type of neuron found in the retina that is capable 
of phototransduction. The great biological importance of photoreceptors is that they 
transform photon light energy (visible electromagnetic radiation) into electrical signals 
that can stimulate biological processes in different ways.  
A mere decade or so ago, rods and cones were considered the only photoreceptor cells 
in the mammalian retina. However, the spectral sensitivity of the circadian system 
provided the initial evidence of an additional photoreceptor system in the retina. 
Later, this theory was supported when genetically modified mice, lacking rods and 
cones, were likewise able to detect light for entraining circadian rhythms, as well as 
other NIF functions (2). Finally, this was confirmed by some studies with totally blind 
humans, who were unable to form images but were nonetheless capable of detecting 
light and inducing acute and long-term non-visual responses (i.e. regulation of 
melatonin secretion), so those people had normally photoentrained behavioural and 
neuroendocrine rhythms (2,4,8).  
The discovery of this non-rod/non-cone novel system, based on the activation of 
photoreceptor transduction cascades within the mammalian retina, not only 
revolutionized our understanding of intrinsic retinal biology and physiology, but also 
defined the important role of light in the non-image forming functions of the retina: 
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the regulation of circadian rhythms and other NIF effects (2,4), therefore, light is 
essential for both image and non-image forming functions. 
Therefore nowadays, rods, cones and these additional photoreceptor system formed 
by the intrinsically photosensitive retinal ganglion cells (ipRGCs), which are structurally 
and functionally different, are all of them considered photoreceptor cells. 
2.1.1.1. Rods and cones: the visual part  
The classical photoreceptor cells are rods and cones, and both express photopigments 
in their membranes, rhodopsins (Opn2) and photopsins (Opn1) respectively, which are 
responsible for detect and transform light into information that is used by the visual 
system for image formation and object tracking (2,3). 
Rods are exquisitely sensitive and are designed for dim light (scotopic) monochromatic 
vision, whereas cones are less sensitive and are specialized for bright light (photopic) 
colour vision and contrast detection. For this, humans have one kind of rods, with a 
sensitivity peak at 498 nm wavelength (Fig. 1), and three cone types: short wavelength 
(S-cones), mid wavelength (M-cones) and long wavelength (L-cones) associated with 
blue, green and red colours, in that order. So, colour vision is mediated by the 
activation of different cone photoreceptors that express different photopsins, which 
show sensitivity peaks at different wavelengths (colours) of light, which are 420 nm, 
534 nm and 564 nm, respectively (Fig. 1) (2,3,10).  
 
Fig. 1. Spectral absorption curves of the short (S), medium (M) and 
long (L) wavelength pigments in human cone and rod (R) cells. 
Rods and cones relay photic information through multisynaptic pathways to the retinal 
ganglion cells (RGCs), the output neurons of the retina, which innervate different areas 
of the brain for complex visual processing (2).  
 
9 
Retina signalling occurs in two directions: vertically and horizontally. The vertical 
neurotransmission takes place predominantly from photoreceptors to RGCs through 
bipolar cells by glutamate release; whilst the horizontal neurotransmission occurs 
through other two types of cells, horizontal and amacrine cells, which facilitate lateral 
connectivity between the photoreceptors and bipolar cells, and the bipolar cells and 
RGCs, respectively by GABA and glycine release (10) (Fig. 2).  
Then, RGC axons carry the information through the optic nerve to the lateral 
geniculate nucleus (LGN) of the thalamus, and other sub-cortical targets, where it is 
integrated and finally leads to vision (10).  
Much more information could be given on vision and its mechanisms, this is only a 
brief touch, but this is not the aim of this project. 
2.1.1.2. ipRGCs: the non-visual part 
A third class of photoreceptor cells was discovered in vertebrates during the 1990s and 
termed intrinsically photosensitive retinal ganglion cells (ipRGCs) because it was a 
subpopulation of RGCs which responded to light intrinsically in absence of rod/cone 
signalling (2,4). As such, the ipRGCs detect environmental illumination and transform 
light into information, which permits human physiology to be optimized and aligned 
with geophysical day-night cycles using neural and hormonal messengers including 
melatonin (5).  
Approximately 3000 ipRGCs are situated in the ganglion cell layer and span the retina 
with their dendrites overlapping in the inner plexiform layer, thus forming a network 
and acting as a syncytium which integrates photic energy over long periods (4). 
Initially, ipRGCs were thought to constitute a uniform population whose predominant 
role was to influence circadian rhythms. However, depth investigations have revealed 
the existence of at least 5 subtypes (M1-M5) of ipRGCs, with different morphological 
and electrophysiological properties, in rodents (11,12). All of them express melanopsin 
(Opn4) in the plasma membrane of their cell bodies, dendrites and axons (4). The 
distinct ipRGC subtypes express varying levels of melanopsin and have different 
patterns of dendrite stratification in the inner plexiform layer, indicating that each 
subtype could play a particular role in detecting light intrinsically and in signalling rod 
and cone information to the brain (2,12). 
Melanopsin is an opsin sparsely distributed in the mammal inner retina, indeed 
specifically expressed in ipRGCs, which functions as a bistable photopigment able to 
regenerate its own chromophore using long wavelength light, whereby the light 
 
10 
activated form is capable of absorbing a second wavelength of light and recycling itself 
back to the inactive form, ready to absorb light and drive more responses; this 
characteristic of bistability is a melanopsin adaptation. For these reasons, melanopsin 
was proposed as the circadian responsible photopigment (4,7,13).  
The melanopsin expressing RGCs demonstrate a characteristic opsin-like spectral 
response curve, with peak sensitivity at short wavelengths (446-483 nm). This ipRGC 
sensitivity peak (480 nm) is also included in blue light wavelength range (450-495 nm); 
therefore these melanopsin expressing RGCs are most sensitive to short wavelength 
light of the blue spectrum region (2,4,6). Moreover, sunlight has been the primary 
stimulus for ipRGCs photoreception throughout human history; in fact, skylight has a 
dominant wavelength of 477 nm, similar to ipRGCs peak sensitivity (5), but during 
twilight, the quality of light changes in three important aspects: the amount of light, 
the spectral composition of light and the source of light or position of the sun. These 
parameters all change in a systematic way and could be used by the circadian system 
to detect the phase of twilight and hence time of day. For instance, when the sun is 
close to the horizon, there is a relative enrichment of blue light in the dome of the sky 
because of the preferential scattering of short wavelengths of light passing obliquely 
through the atmosphere (3).  
The effectiveness of light exposure for ipRGCs-mediated biological effects depends on 
its intensity, duration, spectrum wavelength and timing relative to the phase of the 
circadian rhythm. Thereby, brighter, longer, blue light exposures has been shown to be 
most effective at inducing a wide range of non-visual responses in humans, including 
changes in the melatonin rhythm timing, acute suppression of melatonin secretion, 
phase shifting, photoentrainment, thermoregulation, heart rate variability, improved 
nocturnal sleep quality, treatment of seasonal/non-seasonal depression, and enhanced 
mood/well-being, alertness, reaction time, cognitive performance and vigilance. This 
supremacy of blue light at brain responses was observed as early as 50 seconds after 
the start of the exposure and persisted for 18 minutes of exposure (5,7,8).  
In addition to their intrinsic melanopsin-dependent pathway, the ipRGCs, like all 
ganglion cells, also receive light information secondarily from rods and cones (Fig. 2), 
so they partially contribute to non-image forming (NIF) retinal functions. In fact, these 
melanopsin expressing RGCs are the main link for rod-cone input to circadian timing 
system daily resynchronization, and both classical photoreceptors and ipRGCs are 
necessary to observe a complete response to light (2,4,7,8,14,15).  
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Fig. 2. Light detection in the vertebrate retina. Rods (R) and cones (C) convey visual 
information to ganglion cells (G) via second-order bipolar cells (B). At the first synaptic 
layer, horizontal cells (H) facilitate lateral connectivity and feedback to photoreceptors, 
and at the second synaptic layer in the inner retina, amacrine cells (A) allow lateral 
connections between bipolar and ganglion cells. The optic nerve is formed from axons 
of all the ganglion cells. The subset of photosensitive retinal ganglion cells (pRGCs) also 
detects light directly, using the photopigment melanopsin. Thus, photodetection in the 
retina occurs both in the outer and inner retina [Modified from REF. (13)] 
In the so-called non-image forming pathway, light detection through the ipRGCs is 
transformed into information, non-visual photic inputs, which are directly transmitted 
from ipRGCs to non-visual brain centres including the human body’s master biological 
clock, the suprachiasmatic nuclei (SCN), through a monosynaptic pathway that 
originates in the retina and is called the retinohypothalamic tract (RHT) (4,5) (Fig. 3).  
In addition to their projections to the SCN, ipRGCs also show widespread projection 
patterns throughout the rodent brain, targeting numerous brain regions that have a 
role in driving light-mediated behaviours, such as the olivary pre-tectal nucleus (OPN) 
that regulates pupil constriction (7); the subparaventricular zone (SPZ) and 
intergeniculate leaflet (IGL) of the thalamus, important for the regulation of circadian 
rhythms; the ventrolateral preoptic area (VLPO) and lateral hypothalamus (LH), related 
to sleep regulation and alertness; and the limbic regions medial amygdala (MA) and 
lateral habenula (LHb), implicated in cognitive functions and mood regulation, that 
includes depression and anxiety states (Fig. 3). Therefore, ipRGCs are the leading 
candidates for mediating the effects of light on several behaviours, such as circadian 
rhythms, sleep, alertness and mood (2,8,16). 
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Fig. 3. Schematic representation of the direct ipRGC innervations of the 
suprachiasmatic nuclei (SCN), ventrolateral preoptic area (VLPO) and lateral 
hypothalamus (LH), subparaventricular zone (SPZ) and intergeniculate leaflet (IGL), and 
medial amygdale (MA) and lateral habenula (LHb), via the optic nerve (IIn) and 
retinohypothalamic tract (RHT); and the polysynaptic pathway link between the SCN 
and pineal gland for melatonin production, and other SCN outputs innervations such as 
locus coeruleus (LC) and ventral tegmental area (VTA) [Modified from REF. (4)]. 
 
3. Non-image forming functions 
In mammals, the eye is the only organ capable of detecting light for non-image forming 
(NIF) functions, which are light mediated-behaviours that are not involved in detecting 
contrasts, colour or motion of the visual scene. (2). These NIF functions are mainly led 
by the, now better known, intrinsically photosensitive retinal ganglion cells (ipRGCs), 
but also to a lesser extent by rods and cones. Indeed, several studies conducted on one 
hand with mice lacking rods and reduced number of cones, and the other hand with 
melanopsin knockout mice, exhibited attenuated NIF responses to light; but further 
studies performed with triple-knockout mice (lacking rods, cones and melanopsin) 
revealed a totally unresponsiveness to light, demonstrating that NIF functions in 
mammals are mediated by rods, cones and the melanopsin expressing RGCs (3,14,15). 
These NIF functions include circadian photoentrainment, the tracking of seasonal 
changes and the regulation of sleep, alertness, mood and learning (2). The circadian 
system and photoentrainment explained below have been well studied for a long time, 
but the mechanisms of sleep and mood regulation due to light are still being 
investigated to get more information, so the explanations given later are based on 
information available up to now. 
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3.1. Circadian photoentrainment 
3.1.1. The circadian system 
3.1.1.1. Suprachiasmatic nuclei (SCN) 
The suprachiasmatic nuclei (SCN) of the anterior hypothalamus serve as the body’s 
master biological clock or central circadian pacemaker in animal species that possess 
complex central nervous system (CNS). As mentioned above, this internal biological 
clock is capable of maintaining rhythmicity of circadian functions such as sleep, body 
temperature, hormonal secretion and cognitive performance in the absence of 
environmental inputs, although it needs synchronization of these functions with the 
external environmental time (4,17). 
The SCN also receives information about internal physiological state. These timed SCN 
inputs prepare the body for the fluctuating physiological demands of the solar day, 
such as metabolic, biochemical and physical activities. In the morning, activation of the 
adenocortical axis and the corresponding catabolic processes prepare the body for the 
mental and physical demands of awakening; morning exposure to sunlight increases 
core body temperature, alertness, cognition and brain serotonin levels which enhance 
mood and vitality. As the day progresses, peak cognition occurs commensurate with 
maximal core body temperature. By evening, the SCN actively inhibit cortisol secretion 
and stimulate pineal melatonin secretion, which affects transcription rates in SCN, and 
other hormones, which decrease core body temperature and reduce alertness, and 
allow the anabolic functions of growth and repair to predominate (4,5,17). 
As noted above, apart from its main activity, that is the circadian timing system daily 
resynchronization through the external time cues, the SCN have several downstream 
targets on which have a great influence. These targets include brain regions involved in 
sleep regulation, such as the VLPO and LH, body temperature regulation, hormone 
secretion and cognitive performance. But also other brain areas related to mood and 
motivational states, such as the locus coeruleus (LC), amygdala, LHb and ventral 
tegmental area (VTA) (2,4) (Fig. 3). 
As shown in the figure 3, several of the ipRGC targets also receive innervations from 
the SCN, raising the possibility that in addition to its pacemaker function, the SCN can 
also act as a conduit for light information. This means that light can influence these 
areas through direct projections from ipRGCs and indirectly through the SCN, so, the 
convergence of environmental light information at specific times of the circadian cycle 
may influence the physiological functions of these brain regions (2).  
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3.1.1.1.1. Molecular machinery 
The molecular machinery responsible for the generation of circadian rhythms is really 
complex, with multiple cascades taking place in the nucleus and cytoplasm, which 
contribute to the expression of circadian oscillations and rhythmicity. Indeed, 
endogenous circadian rhythms are generated by oscillating gene expression derived 
from an autoregulatory transcription/post-transcription/translation/post-translation-
based feedback loop (18). The transcription, translation and translocation of these 
clock genes (CGs) vary rhythmically during the day, and these variations are associated 
with changes in the synthesis, sensitivity, efficacy and concentrations of several 
neurotransmitters, neuropeptides and hormones throughout the brain and body, 
which also modulate the molecular machinery of the SCN (17). 
The feedback loop, including nuclear transport and cytoplasmic concentration 
gradients, occurs in neurons; and the system is comprised of two limbs, categorized as 
either positive or negative (i.e., the presence of the factors increases or decreases the 
transcription/translation of some product, respectively). The negative component of 
the feedback loop is dominated by the clock genes Cryptochrome (Cry) and Period 
(Per), which are typically co-expressed; and the positive component includes the 
transcription factors CLOCK and BMAL1. In mammals, Per has three isoforms (Per1, 
Per2 and Per3) and Cry has two (Cry1, Cry2), which are transcribed and translated into 
PER and CRY proteins. The presence of these protein products within the nucleus 
inhibits their own transcription by down-regulating CLOCK and BMAL1 (17,19). 
Though gene expression is endogenously controlled, and hence intrinsically rhythmic, 
there are several mechanisms that entrain the system through various inputs or 
zeitgebers, which manipulate the expression of the cascades that can act to stabilize 
the rhythms, advance, or delay them. For instance, light can influence PER1 and PER2 
expression in the SCN in conjunction with endogenously rhythmic transcription factors 
CLOCK and BMAL1. Light information travelling along the RHT from the ipRGCs 
activates neurons and subsequently engaged intracellular second messenger signalling 
cascades, the most important of which involves cyclic AMP response binding element 
(CREB), whose transcriptional activity acts directly at the PER promoter. As explained 
above, late-night light exposure increases the expression of PER1, resulting in a phase 
advance, whereas early-night light exposure increases both PER1 and PER2 expression, 
which delays the circadian oscillator. The magnitude of the change is in part mediated 
by the intensity, duration, spectrum wavelength and timing of the light pulse (17). 
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Not surprising, given their role as intermediaries between inputs and the molecular 
clock itself, that Per1 and Per2 are among the quickest CGs to adapt to a new circadian 
period; whilst the role of Per3 is less clearly defined with only mild perturbations 
observed when its protein product is absent. A length polymorphism of this gene is 
associated with delayed sleep phase disorder (DSPD), but it is still unclear whether this 
is due to perturbations of the circadian clockwork or represents some role for PER3 in 
sleep homeostasis. Adding further complexity to their regulation, PER protein levels 
are enhanced via Casein Kinase 1E (CK1ε) phosphorylation, a critical agent for the 
maintenance of normal 24 h rhythms (17,19). 
Moreover, Cry1 and Cry2 expression may also be used to quantify circadian phase, 
because Cry1 shortens the length of the circadian cycle whereas Cry 2 lengthens it; but 
in the absence of both isoforms, circadian rhythmicity gradually disappears under 
constant dark conditions. 
Furthermore, several neurotransmitters including serotonin (5HT), norepinephrine, 
glutamate, gamma-aminobutyric acid (GABA) and acetylcholine (ACh) also affect 
functional activity in the SCN. Molecular communication within the SCN is largely 
modulated by colocalization of traditional neurotransmitters with various 
neuromodulators including hormones like melatonin and steroids; neuropeptides such 
as vasoactive intestinal peptide (VIP), arginine vasopressin (AVP), gastrin releasing 
peptide (GRP) and substance P; and intracellular mediators of cellular activity such like 
calbindin, calretinin, pituitary adenyl cyclase-activating peptide (PACAP) and 
neuropeptide Y (NPY). The colocalization of these numerous molecular agents is a 
large contributor to the complexity of SCN regulation; and variable concentrations of 
these molecules alter behavioural state, which can also impact circadian state (17).  
3.1.1.2. Peripheral and slave oscillators 
In addition to timing cues derived from light, clock genes, and other neurotransmitters, 
hormones and neuropeptides, many homeostatic processes, such as metabolism 
(lipids, carbohydrates, proteins and xenobiotic substances), renal (renal plasma flow 
and urine production) and cardiovascular (blood pressure and heartbeat) functions 
exhibit their own circadian oscillation that, in turn, may feedback into the SCN to tune 
the circadian clock (17,18). Therefore, although the SCN is the master pacemaker in 
mammals, there is a complex network of oscillators in other brain regions and 
peripheral tissues. Due to their downstream position relative to the SCN and light, the 
loci responsible for generating these rhythms have been categorized as peripheral 
oscillators. 
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The abundance of mediating factors and environmental inputs targeting the SCN 
potentiate how quickly it is able to adapt to a new circadian phase and CG expression 
within the SCN (18). SCN is the master pacemaker because there is a high degree of 
synchronicity between SCN neurons due to this coupling, which means that 
rhythmicity is maintained in the SCN under conditions that would abolish rhythmicity 
in peripheral oscillators (20). Indeed, due to the hierarchical nature of the circadian 
system, except for a few regions, the rhythmicity of peripheral oscillators depends on 
the SCN; this means that they fail to generate circadian output in the absence of input 
from the SCN, so they are known as slave oscillators. As a result, these oscillators are 
potentially slower to adapt to new schedules than the SCN because they do not 
possess abundant modulatory zeitgeber inputs (17).  
The SCN as the master oscillator and the periphery together form a resonant network, 
which communication occurs via direct neuronal efferents, neuropeptide secretion and 
humoral signals (e.g., glucocorticoids) (18,20,21). Loss of SCN input leads to 
desynchronization of peripheral cell oscillations, decoupling of the circadian physiology 
of cells and organs, and increased risk of disease. Some health problems associated 
with chronic circadian disruption, such as reduced cognitive function and poor health 
outcomes, are likely a product of desynchronization across the central and slave 
oscillators for extended periods of time (22). Furthermore, a lack of coherence in the 
oscillation of individual cells within each system may further contribute to the negative 
outcomes following circadian disruption (4,7,17).  
Moreover, circadian rhythms in clock gene expression, body temperature, feeding and 
activity can entrain peripheral oscillators indirectly (18,20,21). Indeed, some brain 
areas such as the medial amygdale (MA) and the lateral habenula (LHb) can be 
categorized as semi-autonomous oscillators because they are capable of circadian 
rhythm generation in the absence of the SCN, due to the direct ipRGCs innervations 
(Fig. 3). Furthermore, the olfactory bulb has all the characteristics of a master 
pacemaker and appears to be a fully autonomous oscillator such as the SCN (2,4,17). 
So, not all peripheral oscillators need the SCN for circadian rhythm generation, but 
most of them require SCN for external synchronization. 
3.1.1.3. Pineal gland and melatonin 
In mammals, the pineal gland expresses many elements of the phototransduction 
cascade but lacks photosensitivity so appears exclusively secretory, in fact, it is the 
main source of the neurohormone melatonin (3), but not the only one; melatonin 
synthesis also occurs in a variety of tissues ranging from the retina to the gut (17).  
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Several multisynaptic signals from the SCN are conveyed to the pineal gland and 
modulate (suppress or stimulate) melatonin synthesis and release into the 
bloodstream (Fig. 3), this makes melatonin the most closely associated hormone to 
SCN functions (4,5). But melatonin is not only involved in circadian modulation, but 
also is implicated in several metabolic disorders, the majority of which (e.g. obesity 
and diabetes) also have strong ties with abnormal circadian function (17).  
Melatonin production is highly rhythmic, in fact, its rhythm is easily reproducible in an 
individual and, unlike other circadian rhythms, such as core body temperature or 
cortisol levels, it is minimally masked by sleep, activity or stress (4). Melatonin 
synthesis and secretion levels are usually characterized by high night-time levels and 
low daytime levels. Indeed, up-regulation of the rate-limiting enzyme in melatonin 
synthesis (N-acetyltransferase) is directly and immediately suppressed by the SCN in 
response to light; that is, darkness permits pineal melatonin production during the 
proper phase of the SCN cycle, so melatonin levels signal the time of day (5).  
The major metabolite of melatonin is 6-sulphametoxymelatonin (aMT6s), an 
endogenous marker of the circadian clock, whose pattern of production in plasma, 
urine and saliva has been shown to reflect that of melatonin (4). This pattern is 
attenuated under constant light conditions such as modern living conditions (i.e., light 
persisting past sunset), which have dramatically impacted 24h melatonin profiles. 
Melatonin is a potent antioxidant that contributes to the elimination of free oxygen 
radicals and nitric oxide, and also provides numerous other beneficial effects, 
therefore, this attenuation of melatonin levels generates potential health risks (5,17).  
At the SCN, melatonin modulates gene expression derived by the transcription-
translation feedback loop that supports the 24h circadian cycle. The influence of 
melatonin within the SCN takes place at specific melatonin receptors (Mel1 and Mel2), 
and the expression of these receptors oscillates over the 24h cycle (17). So, not only 
the concentration of melatonin fluctuates across the cycle, but also the ability of 
melatonin to influence the SCN varies across circadian time. 
3.1.2.  Photoentrainment  
Photoentrainment is the main factor responsible for synchronising the endogenous 
circadian rhythms to the 24h day, thus serving to optimise the timing of the body’s 
physiology and behaviour with the environment (4,7).  
In mammals, the retina is solely responsible for photoentrainment, which linked to 
melanopsin, differs from image detection, produced by rod and cone opsins, because it 
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requires higher threshold light intensities (up to 200 times greater than that required 
to elicit a visual response) over a long period of time. This happens because ipRGCs are 
relatively insensitive to short duration stimuli, that is, less sensitive and slower to 
respond to light stimulus than rods and cones, which exhibit a rapid, heightened 
response to the onset of a bright pulse of light, followed by a slow decay, even after 
the stimulus is extinguished (2,4,5,14).  
Thereby, non-visual retinal ganglion photoreceptor responses to properly timed bright 
light exposures help assure effective circadian photoentrainment and optimal diurnal 
physiological processes (5), but also a train of bright, short wavelength light flashes, 
that predominately stimulate S-cones, could provide photic information to the SCN 
without necessarily evoking a direct, high-threshold and slow-responding 
phototransducing response from these ipRGCs (14).  
3.2.  Regulation of sleep and alertness 
Impaired sleep is a common problem, especially among older adults, and is associated 
with reduced daytime function, in addition to increased falls and injuries, which raise 
health care costs and reduce quality of life (23). Sleep timing, depth and duration are 
regulated by homeostatic and circadian factors. So, proper alignment between the 
circadian and homeostatic mechanisms improves the quality of sleep; and the amount 
and quality of light striking the retina is really important for this improvement. Light 
influences sleep through changes in circadian photoentrainment, but also directly 
affects sleep onset and homeostatic sleep drive (2,4,6). In this way, light, the circadian 
clock and sleep may closely interact to let organisms to adapt to their environments.  
Sleep and wake are modulated by interplay between the light and dark signalling 
through the rod-cone and melanopsin-based photoreceptive pathways. Despite this, 
some studies revealed a significant suppression of nocturnal melatonin and delayed 
sleep onset following exposure to blue-enriched light, suggesting that these effects 
were mediated presumably by the melanopsin rather than the photic system (4,6). 
Nonetheless, humans with deficits in either retinal pathway could be particularly 
vulnerable to acute effects of light and dark on sleep and wakefulness.  Indeed, some 
sleep disorders result from defective light processing, owing to ipRGC malfunction, or 
due to inadequate light entering the eye to stimulate opsins (4,5). 
Sleep disorders specifically related to ipRGC depletion, which include interrupted 
sleep, increased sleep latency, short sleep duration, daytime sleepiness, and reduced 
alertness and performance during waking are those observed in blind individuals; and 
the severity and prevalence of sleep disturbances is thought to be higher in those with 
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no perception of light. For instance, free-running circadian disorder (FRD) in blind 
people without ipRGC photoreception is most likely the direct result of ipRGC loss, 
although inadequate environmental light exposure can also cause free-running 
circadian rhythms in sighted people (4,5). 
FRD is characterized by a progressively deviation of the phase of physiological cycles 
and the return to environmental day-night cycles after days or months. This happens 
because of the repetitive cycling without daily synchronization owing to the absence of 
environmental timing cues that makes the SCN cycle daily at their own intrinsic period, 
independently of geophysical day-night cycles. Related to this, most totally blind 
individuals have abnormal or free-running circadian rhythms, although recently, dim 
light melatonin onset (DLMO) and core body temperature (CBT) have been proven 
useful in diagnosing and assessing FRD of these individuals, who then typically entrain 
with daily exogenous melatonin, which can improve their quality of life and possibly 
reduce otherwise increased early mortality risks (4,5).  
Other disorders like FRD in sighted individuals, advanced or delayed sleep phase 
disorder (ASPD or DSPD), shift-work disorder (SWD), jet lag disorder (JLD) and irregular 
sleep-wake rhythm (ISWR) are due to light stimulating melanopsin at ‘wrong times’ 
during the circadian cycle. Therefore, both changes in the light environment and poor 
sleep are associated with general alterations in health including mental health issues, 
such as seasonal affective disorder (SAD), depression and cognitive dysfunction, which 
reciprocally can cause disturbed sleep (2,4,17,23). 
Particular attention has been given to understanding the role of sleep deprivation in 
the genesis of these health problems. Sleep deprivation has been shown to result in 
cognitive function deficits, including negative effects on learning and memory, 
alertness and concentration. The sleep disruptions that precipitate an episode of 
depression have been well characterized; interestingly, acute sleep deprivation has a 
robust antidepressant effect; however, the chronic sleep deprivation, such as that 
associated with shift work, leads to mood disturbances (2).  
Most of the disorders listed above are complex and likely to result from a combination 
of endogenous variation in the circadian oscillator, age, gender, morningness or 
eveningness preference, genotype, behaviours and response to zeitgebers (4).  
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3.3.  Mood and cognitive performance 
Ambient light and its physical characteristics emerge as important modulators of brain 
function and cognition. Initially, it was thought that mood and cognitive disorders 
associated with changes in light exposure were caused by disruptions in circadian 
rhythms and sleep. Indeed, in humans, circadian rhythmicity influences numerous 
cognitive processes including attention, executive functions and memory. Accordingly, 
the effects of light on the circadian system have been thoroughly studied, with a focus 
on how changes in the light environment lead to changes in circadian rhythms that, in 
turn, influence sleep and contribute to alterations in mood and cognitive function, 
essentially suggesting that the effects of light on mood and cognitive functions are 
secondary. This is known as the indirect pathway by which changes in the light 
environment cause mood and cognitive alterations (Fig. 4) (2,8,24). 
But later studies have revealed that the effects of light on mood are not solely an 
outcome of circadian rhythm disruption, but also have a direct, clock-independent role 
in influencing these functions. This is known as the direct pathway by which light 
produces changes directly in mood and cognition (Fig. 4). In fact, regions of the brain 
that are involved in attention, alertness, cognitive function and emotional processes 
respond preferentially to 480 nm blue light, the wavelength that maximally activates 
melanopsin, even in blind subjects, which provides an additional support for the role of 
ipRGCs in these and other NIF functions in humans (2,8,24).  
 
Fig. 4. Schematic representation of the indirect pathway, in which light can regulate 
mood and learning secondarily to sleep and circadian rhythms modulation, and the 
direct pathway, in which light can directly affect mood without disrupting sleep or 
causing circadian arrhythmicity. All of these light effects are mediated by ipRGCs 
[Modified from REF. (2)] 
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4. Perturbing NIF functions by light and consequences for health 
4.1.  Physiological alterations: chronodisruption 
4.1.1. Light alterations and schedule changes 
Light during the day or light at night affects different on human physiology and 
behaviour, especially, blue light. Indeed, some disorders are due to light stimulating 
melanopsin at ‘wrong times’ during the circadian cycle (4,6). The artificial lighting has 
enabled us to use more hours of the day, but it has initiated the restructuring of the 
workday and the shift away from activity in alignment with the solar day. Although this 
has been thought to increase productivity, it comes at a considerable cost, which is 
irregular night time light exposure. Furthermore, the impact that light has on 
physiological functions makes irregular light exposure potentially detrimental to health 
and wellness. In fact, inadequate environmental light, and/or ganglion photoreception, 
can be implicated in the manifestation of health problems observed, for example, in 
shift workers. These range from cardiovascular disease to mood disorders, going 
through circadian disruption, insomnia, depression, systemic disorders and possibly 
early mortality (2,5). Irregular light exposure thus becomes an important risk factor for 
developing health problems.  
This risk has the potential to be exacerbated in the presence of additional factors, such 
as chronic stress or genetic susceptibility factors. Indeed, several genetic factors have 
been implicated as the underlying cause of psychiatric diseases, and chronic stress is 
known to influence circadian rhythms and sleep, in addition to have deleterious effects 
on health. Hence, compounded with the presence of irregular light exposure, these 
factors could interact and lead to a higher incidence of depression and other 
neurological disorders that are prevalent in society. For instance, morning bright light 
shortens sleep duration, whilst evening light decreases sleep propensity. Therefore, 
prolonged nightlight exposure such as that obtained by artificial lighting can cause 
circadian arrhytmicity, disrupt sleep-wake cycles and increase depression-related 
behaviours and deficits in learning and memory (2,4,6). Some of these disorders also 
appear due to seasonal changes in day length, shift work and transmeridian travels. 
4.1.1.1. Seasonal changes in day length 
Sunlight's importance is highlighted by seasonal and weather-related neuro-
psychological disorders that would not occur if indoor lighting were sufficient for all 
neurobiological needs. Sunrise occurring later during the winter months causes a delay 
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in circadian rhythmicity; this seems to lead to dissociation between sleep-wake cycles 
and other peripheral circadian rhythms that are more tightly coupled to the central 
circadian oscillator (2). Indeed, reduced sunlight exposure in sighted individuals can 
cause insomnia, free-running rhythms, extreme flattening of hormonal profiles, 
depression and cognitive difficulties, which are reversible with restoration of adequate 
sunshine. Therefore, environmental illumination is inversely correlated with insomnia 
and depression, both of which increase with aging (5).  
Strong support for this delayed phase shift hypothesis lies in the antidepressant effects 
of morning exposure to bright light, which causes an advance in the phase of the clock. 
Despite that depression occurs secondarily to changes in sleep, it is also a direct 
manifestation of reduced light levels, or short photoperiods, owing to the shorter day 
length, as those experienced during winter months, that induce hippocampal learning 
deficits and depression-related behaviours, such as the seasonal affective disorder 
(SAD), a form of depression in which the onset of symptoms, like disabling depression, 
hypersomnolence and weight gain, is coincident with decreasing day length during 
autumn and winter months. The prevalence of SAD is greater in populations living at 
higher latitudes, where the seasonal changes in day length are more extreme. 
Furthermore, polymorphisms in the gene encoding melanopsin (Opn4) and decreased 
retinal sensitivity in the winter months is associated with SAD (2,5,8). Moreover, two 
major hypotheses have been put forth to explain this seasonal form of depression: 
alterations in the daily rhythms of melatonin release and circadian phase shift, both 
related to changes in the usually light detection. 
Although phase delays have been observed in most patients with SAD, a minority of 
them show phase advances, indicating that they should respond better to evening light 
treatment. Indeed, some studies have shown that evening light treatment is as 
effective as an antidepressant as morning treatment. Thus, there are perhaps two 
groups of patients with SAD — phase advanced and phase delayed — that would 
benefit from light treatment at different times of the day (2,5).  
Seasonal mood changes are not restricted to SAD. In fact, seasonal fluctuations in 
mood have been observed in many patients with bipolar disorder, characterized by a 
profound switch in mood between periods of mania and depression. Shifts to the 
depressive phase have been observed to begin in autumn as day length decreases and 
often persist throughout the winter. By March, when day length begins to increase in 
the northern hemisphere, manic episodes become more prevalent, a phenomenon 
nicknamed ‘March madness’. The explanation for these seasonal changes is similar to 
that suggested for SAD. Strong support for this explanation lies in bright light 
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treatments, which have therapeutic effects in patients with bipolar disorder who 
experience seasonal fluctuations. In addition, bright light treatment can have a mania-
inducing effect, providing further support for the influence of light on mood (2).  
Moreover, non-seasonal depression is also closely associated with reduced light 
exposure (5), thereby, in addition to be effective and useful in the treatment of SAD 
and bipolar disorder, bright blue-filtered light treatment, delivered in the morning via 
light boxes, has resulted in a reduction of depressive symptoms and improved sleep 
efficiency, in older adults suffering from non-seasonal major depressive disorder (23). 
Finally, circadian rhythm disruption also negatively impacts reproduction by altering 
hormone profiles, reproductive timing and fertility. Unlike humans, this is common in 
animals, especially in many avian and other species which reproduce seasonally (17).  
4.1.1.2. Shift work 
As already mentioned, the advent of artificial lighting has enabled us to use more 
hours of the day and create disruptive schedules such as shift work. Under these 
conditions, individuals are exposed to excessive night time light and alter their sleep-
wake schedule, which causes asynchrony between the circadian and sleep systems. 
The attempt to remain awake at night and sleep during the day can lead to sleep 
deprivation, because daytime sleep tends to be more fragmented. The risks associated 
with these disruptions include safety hazards and extensive health problems, which 
range from mood disorders to cancer (2).  
Particular attention has been given to understanding the role of sleep deprivation in 
the genesis of these health problems. Indeed, sleep deprivation has been shown to 
result in cognitive function deficits, including negative effects on learning and memory, 
alertness and concentration. The sleep disruptions that precipitate an episode of 
depression have been well characterized. Interestingly, acute sleep deprivation has a 
robust antidepressant effect; however, the chronic sleep deprivation that is associated 
with shift work leads to mood disturbances (2,34).  
Various lifestyle changes coincide with shift work and, rather than a reflection of poor 
decision-making, it may be that a maladapted circadian system is triggering behaviour 
and metabolic changes that culminated in the expression of fatigue or increased 
preference for fatty foods, thereby exacerbating the development of disease states 
that involve circadian components such as cancer, diabetes and coronary problems. 
Cognitively, shift workers exhibit increased rates of irritability, affective disorders and 
memory impairments. Under such adverse conditions, sleep-wake cycles become 
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disrupted and time-inappropriate cues such as night-time light exposure and eating 
create conflicting signals in the SCN and peripheral oscillators, or altered cellular 
mechanics (17). 
On the one hand, night-time light exposure is associated with altered 5-HT processing 
in the SCN, which affects downstream structures related to cognition as well as 
hypothalamic nuclei that influence metabolism and peripheral circadian oscillators. In 
addition, light at night affects secretion and receptor density of melatonin, a potent 
antioxidant whose decreased efficacy is involved in the development of premature 
aging, heart disease or cancer. Moreover, working at night also results in night-time 
eating which is associated with a preference for high sugar and/or fat foods. In 
addition to the increased consumption of fats/sugars, lipid and glucose metabolism is 
altered resulting in increased adiposity and insulin insensitivity resulting in increased 
body mass index (BMI). Increased BMI leads to altered leptin/ghrelin signalling that 
feeds back to the hypothalamus, further altering metabolism (17). 
In short, disrupted circadian rhythmicity could be affecting the whole body through 
both altered metabolic functions and subsequent behaviour modifications, producing a 
cycle characterized by altered cellular machinery, subsequent changes in diet choices 
and exercise, and ill health. When combined, various disease states begin to emerge 
such as diabetes, obesity, or cardiovascular disease (17).  
4.1.1.3. Jet lag / Transmeridian travel 
The ability to travel rapidly across time zones has the unfortunate consequence of 
desynchronizing the circadian system. Many individuals have experienced the general 
malaise associated with transmeridian travel, which is known as jet lag and includes 
poor mood and cognitive impairments (2). The involvement of glucocorticoids in 
resetting the phase of the circadian clock has highlighted their possible contribution to 
the mechanisms underlying the effects of jet lag (35). Indeed, altered cortisol rhythms 
have been observed subsequent to transmeridian travel (36). In addition, it was found 
that chronic transmeridian travel occurring at least once per week for 1 to 4 years 
resulted in cognitive deficits, which were possibly due to chronic circadian disruption 
and/or chronically increased cortisol levels (2). Moreover, a study showing that 
fluoxetine (Prozac) modulates levels of corticosterone to alleviate depression in mice 
maintained under irregular light schedules, further suggests that this mechanism could 
underlie the depression associated with jet lag (37).  
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4.1.2.  Alterations in ipRGCs and light perception 
As explained above, in humans, melanopsin expressing RGCs are responsible for 
mediating the effects of light on several behaviours, such as circadian rhythms, sleep, 
alertness and mood. This happens through complex interactions of several 
neurological pathways, so may exert influence on both maintaining health and the 
expression of disease (2,4,5). 
These ipRGCs are susceptible to primary dysfunction, but, while these cells do not 
make a significant contribution to image formation, their loss leads to substantial 
impairment of non-image forming functions (15). For example, cell depletion, in 
conditions such as inherited or acquired optic neuropathies like glaucoma, or 
neurodegenerative conditions like Parkinson disease, have shown alterations in the 
retinal dopamine-mediated neurotransmission, also involved in transmission across 
the retinohypothalamic tract (RHT) (4,5).  
Furthermore, ipRGCs are inherently photosensitive, with persistent responses when all 
rods and cones have been photobleached. They respond to light even when physically 
dissociated from the retina. But when they are subjects of disorders influencing light 
activation of retinal ganglion photoreceptors, usually secondary to common causes of 
light transmission reduction, such as ageing and cataract formation, it can result in 
circadian asynchrony and affects physiological function. In fact, melanopsin depletion 
at certain times not only could contribute to the development of insomnia, yet also 
could cause depression and cognitive decline, and affect other systems leading to 
gastrointestinal and cardiovascular diseases, diabetes and cancer (4,5), between 
others (Fig. 5).  
Therefore, circadian rhythms influence metabolic cascades in numerous domains and 
links occur between several diseases and circadian rhythm disruption. Indeed, changes 
in metabolic functions in many disease states are related to the molecular machinery 
that underlies the circadian system; and abnormal circadian function is related to 
diseases with metabolic components. But in addition, circadian dysfunction can be 
elicited through environmental manipulations such as night light exposures, and not 
just innate malfunctioning of the clock system (17).  
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Fig. 5. Diagram with some examples of how circadian disruption negatively impacts the brain 
and the digestive, cardiovascular and reproductive systems. Though the diagram displays 
unidirectional affects, there are various feedback loops that exist within the system and 
interactions that occur between these systems [Modified from REF. (17)]. 
4.1.2.1. Parkinson disease 
Parkinson disease (PD) is a neurodegenerative disorder with an incidence and 
prevalence increased with age. The original description of ‘the shaking palsy’ was 
focussed on the motor features of the disorder, but later studies revealed that non-
motor aspects or additional characteristics including circadian rhythm, sleep and mood 
disturbances, cognitive decline, dementia, hyposmia and autonomic failure were also 
related to PD. Furthermore, visual symptoms are common and evidence exists of visual 
dysfunction at several levels of the visual pathway in this disorder; which includes 
physiological, electrophysiological and morphological evidence of disruption of retinal 
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structure and function, in addition to disorders of cortical visual processing. All these 
features affect sleep and general quality of life of people suffering from this disease. 
Parkinson disease is due to the primary degeneration of nigrostriatal dopamine (NSD) 
pathways, which leads to a lack of dopamine, also involved in transmission across the 
RHT. So, dopamine replacement might additionally activate the circadian system and 
thus be used as a treatment for these diseases. Conversely, unopposed or excessive 
melatonin could contribute to exacerbating motor dysfunction, hypotension and body 
weight regulation, in addition to cause excessive daytime somnolence. Theoretically, 
suppressing melatonin production with bright light may have some therapeutic value 
as adjuvant therapy in PD, although the presence or absence of melatonin could affect 
differently depending on the characteristics of each patient (4,10).  
4.1.2.2. Age-related disorders 
Daily light exposures necessary for visual and non-visual photoreception depend on 
numerous intrinsic and extrinsic factors, and oscillations of various circadian 
parameters decline with age; these attenuations are observed in circulating levels of 
plasma cortisol and testosterone in aging men.  
Moreover, visual function changes as we age, in part due to age-related diseases of the 
eye such as cataract formation, macular degeneration, senescent miosis, diabetic 
retinopathy and glaucoma. These age-related ophthalmological diseases contribute to 
deteriorate visual acuity, contrast sensitivity, colour vision and dark adaptation, in 
addition to central dysfunction due to visual cortex pathology, and co-existing 
cognitive decline (5,10,17).  
In addition, ageing is accompanied by many changes within the eye physiology 
including alterations in pupil size, lens transmission and number of photoreceptors. It 
has been demonstrated that there is a reduction in the size of the S-cones and 
melanopsin-RGCs population with age that could diminish the photic signal 
transmitted to the brain. Alternatively, an increased density and yellowing of ocular 
lens, common in older people, diminishes the amount of short wavelength blue light 
reaching the photopigments involved in the non-visual photoreceptor system. This 
places them at risk for retinal ganglion photoreception deficiency, possibly 
contributing to age-related insomnia, depression and cognitive decline, thus increasing 
neurobiological morbidity (4,5,7).  
The most notable effect of aging could be its association with increased disturbances in 
the timing, duration, and quality of sleep, including problems falling asleep, night 
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awakenings, waking too early and daytime sleepiness, which may reflect changes in 
the circadian timing system and/or the sleep homeostat. Alterations in this balance 
can have a substantial impact on their quality of life and daytime functioning. So, 
proper alignment between the circadian and homeostatic mechanisms is necessary to 
produce consolidated sleep at appropriate time (5,7).  
Further, circadian deficits have long been a hallmark of demented states. Formerly 
referred as nocturnal delirium, sun-downing, characterized by increased levels of 
agitation and disorientation at particular times of day, is one of the earliest observed 
cognitive phenomena related to circadian function. But the age-associated decline in 
brain function is not restricted to the SCN, these changes are linked to alterations in 
oscillating levels of melatonin, 5HT, SCN morphology and synchronicity with extra-SCN 
CG activity in dementia, a heterogeneous group of disorders that can be associated 
with vascular failure, cell death or the accumulation of plaques, in addition to frequent 
night-time awakenings characteristics of the sleep profiles of aged individuals (17).  
All these problems also could arise from changes in the light input pathway, which 
synchronizes the circadian clock to the local LD cycle. In fact, clock genes involved in 
the molecular mechanism that drives circadian oscillations in all cells of the body can 
have their expression levels modified by exposure to light.  
As mentioned above, circadian rhythm disturbances parallel the increased prevalence 
of sleep disorders in older adults, especially in those with cognitive impairment. 
Therefore, therapies, especially non-pharmacological treatments, such as light 
therapies specifically targeting the regulation of the circadian system could be used to 
alleviate many sleep disorders in elderly. Current recommendations for these light 
treatments require the patients to sit in front of a bright light box for at least 1 hour 
daily, which perhaps limits their willingness to comply (23).  
Despite this, new methods, like the use of a mask delivering light pulses for stimulating 
the human circadian system through closed eyelids during sleep, have been studied 
and not only are efficacious for significantly nocturnal melatonin suppression and of 
phase delaying dim light melatonin onset (DLMO) in older adults, but also lead to 
better compliance, because patients receive light treatment while sleeping in a home 
setting. This method offers great promise for clinical studies aimed at correcting 
circadian misalignment, because light applied close to the minimum core body 
temperature (CBTmin) maximally shift the timing of the circadian pacemaker, that is, 
retinal light exposure just prior to CBTmin maximally delay the timing of the biological 
clock, while light exposure just after CBTmin maximally advance circadian phase (14,23). 
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Returning to the clock genes involved in the molecular mechanism that drives circadian 
oscillations in all cells of the body, specifically in humans it has been demonstrated 
that blue light (460 nm) is more effective than green light (550 nm) in influencing the 
expression of PER2 in oral mucosa cells of young individuals (25), but not in older men. 
In addition, the melatonin suppression and alerting data also demonstrate impairment 
in the ability of blue light to induce acute responses in older people (26) (Fig. 6). 
Otherwise, blue light is able to shift the timing of clock gene expression in peripheral 
oscillators; this has been demonstrated using PER3 expression in the peripheral 
leukocyte clock as a molecular marker. Older people often experience an advance in 
the time that they fall asleep and wake up, and there is also an alteration in the phase 
relationship between the sleep/wake cycle and both the plasma melatonin and core 
body temperature rhythms. The timing of the PER3 peak was significantly advanced 
following blue but not green light in both the younger and older groups, similar to the 
melatonin rhythm. So, the phase advancing response to blue light is sustained in older 
individuals (7,27) (Fig. 6). 
In summary, these studies have demonstrated that acute responses to blue light 
(melatonin suppression, increased alertness, increased PER2 expression) are impaired 
in older individuals whereas the phase advancing effects of blue light (plasma 
melatonin rhythm, PER3 expression rhythm in leukocytes) are sustained. These 
differential effects may reflect differences in the detection or processing of the photic 
signal or be a function of the time-course of the response (Fig. 6) (7).  
 
Fig. 6. Summary of age-related changes in ocular physiology and non-visual responses to 
blue light [Modified from REF. (7)]. 
The restoring of photoentrainment and neurobiological response might be achieved by 
lens replacement with a prosthetic intraocular lens (IOL) implant with blue light 
spectral transmission characteristics, or cataract surgery, which provides older adults 
with more youthful circadian photoreception. Indeed, patients undergoing IOL and 
cataract surgery show decreased incidence of insomnia and daytime sleepiness (4,5).  
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In general, in the reduction of ipRGC functions with aging, environmental lighting 
might also be modulated to simulate timed exposure levels of more youthful circadian 
photoreception and in part, reverse the chronic sleep disturbance, depression and 
cognitive dysfunction among older individuals. Then, another method of improving 
sleep/activity rhythms in older people may be to boost the amplitude of the circadian 
clock by strengthening the LD cycle. This can be done by making sure that the light 
period is as bright as possible and the dark period as dark as possible to provide the 
best relative contrast and a clear signal to the clock (4,7).  
Moreover, a clear link has been established between circadian disruption and 
dementia and evidence is beginning to accumulate indicating melatonin administration 
in conjunction with exercise may be neuroprotective, at least in animal models (28). 
And another link between circadian disruption and cognitive health has also been 
described whereby circadian therapies (e.g., bright light therapy) may reduce the 
severity of sun-downing (17,29).  
4.1.2.3. Obesity and diabetes 
There is considerable epidemiological evidence for a relationship between abnormal 
circadian rhythms and metabolic changes related to obesity and diabetes in humans. 
Increased adiposity and altered glucose metabolism create a positive feedback loop 
that results in more profound adiposity (i.e., obesity) and poorer glucose metabolism 
that can culminate in diabetes or untimely death. This is due to the extensive 
connectivity between SCN and various hypothalamic nuclei associated with 
metabolism that regulate pancreatic, hepatic and adipocyte functions (17,18). Indeed, 
metabolic demand, such as lipid concentrations in plasma and the accessibility of fat 
stores, varies across the circadian cycle. Accordingly, as such, organisms have evolved 
to regulate energy metabolism across their circadian cycle (17,30).  
In addition to metabolism, circadian disruption also influences food related 
behaviours, which is constrained by a complex series of feedback loops that involve 
several molecules (e.g., ghrelin and leptin). These cascades are one example of 
endogenous peripheral oscillators that provide signals to the SCN about time of day. 
However, this feedback is reciprocal, for instance, in addition to circadian disruption 
possibly contributing to the development of diabetes; diabetes might also disrupt 
circadian rhythms associated with metabolism (17,22). 
Furthermore, circadian disruption also affects gene expression and molecular 
concentrations of CGs in liver, adipose tissue and muscle, leading to altered 
experiences of hunger, satiety, restlessness or food preferences. The aberrant CG 
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expression induced by an episode of circadian disruption, or as a consequence of CG 
mutations, results in altered glucose/insulin metabolism, hepatic responses and 
feeding patterns, which could underlie an improper diet and poor food choice. For 
instance, individuals employed on rotating shift work schedules have higher body mass 
index (BMI) scores, this happens because of alterations in diet preferences in shift 
workers, who tend to eat more meals/snacks, or consume carbohydrates and added 
fat foods. Even sleep deprivation is also associated with alterations to the propensity 
of humans to overeat (17). 
Despite this, in humans, even when food administration is controlled, the highest 
concentrations of most lipid products peak around midday, which demonstrates that 
the circadian component of this loop acts independently of sleep, feeding, and fasting 
schedules (17,30).  
4.1.2.4. Cancer 
The link between circadian function and cancer is complex. The concentrations of 
various molecules related to cell proliferation, differentiation, and apoptosis cycle 
across the circadian period, as do their ability to affect various biological systems (e.g., 
SCN), are altered in various cancer states. Indeed, disrupted patterns of the underlying 
molecular oscillations, in addition to sleep disturbances, are observed in cancer 
patients and are associated with decreased survival rates. In short, cancer's molecular 
machinery takes advantage of disrupted circadian rhythmicity and then hijacks 
molecular cascades that result in further disruption the circadian system.  
Epidemiological and experimental association between cancer survival and prevalence 
rates and circadian disruption have both been reported. Circadian disruption is often 
affected in disease states, but exogenous inputs in our lifestyle choices, such as 
frequent transmeridian travel, can also affect the system. Shift work is another 
example of a circadian disrupted lifestyle, indeed, considerable evidence linking shift 
work to increased prevalence of cancer lead the International Agency for Research on 
Cancer to classify circadian disruption shift work as a probable human carcinogen; this 
classification highlights the role of the circadian system on cancer (17).  
The link between circadian disruption and cancer has been noted for a range of tissue 
types (e.g., breast, prostate, pancreas, skin) and various time of day affects in 
oncogene activity have been observed. Breast cancer alterations may be the result of 
interactions between circadian gene expression and androgens, but there are likely 
other systems affected; for instance, a functional CLOCK protein has been implicated 
with breast carcinogenesis without circadian disruption (17,31).  
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Another potential mechanism is an alteration in circulating levels of melatonin 
associated with night-time light exposure and activity in individuals employed on shift 
work schedules, in fact, light exposure during the dark phase of the circadian cycle is 
associated with decreased melatonin expression. Furthermore, subjects who do not 
sleep during the peak hours of melatonin expression have the highest increased 
incidence of breast cancer; this may occur because melatonin is reported to eliminate 
nitric oxide and other reactive oxygen species. Even colorectal and prostate cancer 
tumorigenesis and survival are also associated with sleep/activity cycles (17,32).  
4.1.2.5. Cardiovascular consequences 
The incidence and severity of cardiovascular events varies across the circadian cycle, 
indeed, they are more often fatal if they occur early in the morning. The link between 
circadian rhythms and cardiovascular function is further supported by the examination 
of heart and renal function in mutant hamsters. The observation of pathology in heart 
and kidney tissue indicates that the effects of circadian disruption on organ health are 
pervasive. Furthermore, lesions of SCN ameliorate these changes indicating that it is 
not circadian rhythm disruption per se that elicits the ill effects, but the 
desynchronization between central and peripheral oscillators that elicit cardiovascular 
and renal effects. Despite this, these effects do not appear to be mediated by circadian 
dysregulation alone, but rather are the product of a lack of coherence between the 
individual’s innate circadian timing system and the world around them (17,33).  
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VII. CONCLUSIONS 
The discovery of the ipRGCs and the role of melanopsin in circadian pathways have 
contributed to our understanding of light and circadian biology. Light is not only 
necessary for vision, but also is essential for circadian photoentrainment, sleep and 
mood regulation, cognition and health.  
Circadian function, cognition and health exist as a complex reciprocal network in which 
all components exhibit multidirectional effects on the other systems. Under healthful 
conditions, these interactions create a robust, dynamic circuit that allows the organism 
to adapt well to its environment. But when disease strikes a component of the system, 
the effects propagate cascade and can lead to a decline in the function of all systems.  
The misalignment of these systems can perpetuate disease states that can culminate in 
damage.  For instance, alterations in ipRGCs can result in sleep and mood disorders 
directly associated with light perception, or secondarily to circadian disruption. In turn, 
circadian rhythm disturbances, insomnia and depression are significant risk factors for 
developing some diseases such as obesity, diabetes, cancer, cognitive deficiencies, 
dementia and cardiovascular diseases, even, premature mortality.  
It is important to identify the mechanisms and effects within the system from a genetic 
level to an epidemiological one; because only with complete understanding will be 
possible to mitigate the effects of abnormal circadian function on health. 
The reliance of the circadian system on environmental inputs makes it possible to 
manipulate circadian rhythms by altering the timing of relevant events without 
physical manipulation of the brain, which reduces the surgery-associated risks. All 
circadian rhythm disturbances are at least partially, if not fully, amenable to planned 
sleep schedules, timed light exposure and exogenous daily melatonin administration. 
Focusing on the effects of light on the body, appropriately timed blue-enriched bright 
light, such as outdoor daylight, is really useful for photoentrainment and effective in 
decreasing sleepiness and enhancing performance and cognitive tasks in humans. In 
addition, blue light is efficient in ipRGC-mediated melatonin suppression, so it could be 
used as adjuvant therapy in Parkinson disease; it is the treatment of choice of the 
seasonal affective disorder (SAD) and it is also emerging as a promising treatment for 
many other psychiatric disorders. 
Broadband polychromatic light sources are used to ensure optimal stimulation of the 
visual system, without concerning the optimizing of light for the non visual system; 
artificial light sources of indoor environments deprive us of the blue light we need. 
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In addition, ocular pathology and the resultant reduction in retinal phototransduction 
lead to circadian disturbances and sleep disorders, with downstream effects on our 
overall physiological integrity.  
Thus patient lifestyle education and more effective architectural designs for lighting 
environments like schools and work could be potentially beneficial for the population. 
As final conclusion, we could say that the knowledge of non-visual effects of light on 
the body, both at biochemical and physiological levels, allows pharmacists to give 
advice to patients about the most appropriate behaviour patterns to follow regarding 
light exposure and nutrition, to get good health and quality of life. 
 
VIII. PERSONAL REFLECTIONS 
First, it should be clear that the temporal dynamics of the human circadian system is 
more poorly understood than its spectral and absolute sensitivities; therefore, more 
basic research is needed to elucidate the temporal characteristics of human circadian 
phototransduction. 
However, some recommendations could be given to improve the lifestyle of the 
population in general, such as avoid exposure to permanent dim light, or to bright light 
at certain times of the day, especially at night; and more specifically to teenagers and 
college students, who spend many hours at the computer, which can alter their 
circadian rhythms, mood, and sleep schedules.  
Moreover, it would be interesting that this information could reach designers and/or 
specialists in lighting in schools and workplaces, especially those designed to hold 
people inside 24 hours a day (e.g., night shift workers or hospitalized patients). This 
would allow them to make architectural designs more appropriate to people's needs 
and thus avoid the onset of disorders related to exposure to light at wrong times. 
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